Adient plc — Q4 FY26 Earnings Summary

Financial Performance:

• Net sales for the three months ended September 30, 2026, were $3,730 million, compared to $3,688 million in the prior year period.
• Net sales for the twelve months ended September 30, 2026, were $15,168 million, compared to $14,535 million in the prior year period.
• Net income (loss) attributable to Adient for the three months ended September 30, 2026, was a loss of $47 million, compared to a profit of $18 million in the prior year period.
• Net income (loss) attributable to Adient for the twelve months ended September 30, 2026, was a loss of $17 million, compared to a loss of $281 million in the prior year period.
• Diluted earnings (loss) per share for the three months ended September 30, 2026, was $(0.62), compared to $0.22 in the prior year period.
• Diluted earnings (loss) per share for the twelve months ended September 30, 2026, was $(0.22), compared to $(3.39) in the prior year period.
• Adjusted EBITDA for the three months ended September 30, 2026, was $229 million, compared to $226 million in the prior year period.
• Adjusted EBITDA for the twelve months ended September 30, 2026, was $884 million, compared to $881 million in the prior year period.
• Adjusted EBITDA margin for the three months ended September 30, 2026, was 6.1%, compared to 6.1% in the prior year period.
• Adjusted EBITDA margin for the twelve months ended September 30, 2026, was 5.8%, compared to 6.1% in the prior year period.
• Free cash flow for the three months ended September 30, 2026, was $61 million, compared to $134 million in the prior year period.
• Free cash flow for the twelve months ended September 30, 2026, was $222 million, compared to $204 million in the prior year period.
• Total debt was $2,352 million as of September 30, 2026, compared to $2,397 million as of September 30, 2025.
• Cash and cash equivalents were $886 million as of September 30, 2026, compared to $958 million as of September 30, 2025.
• Net debt was $1,466 million as of September 30, 2026, compared to $1,439 million as of September 30, 2025.
• Net leverage ratio was 1.66x as of September 30, 2026, compared to 1.63x as of September 30, 2025.
• Restructuring and impairment costs for the three months ended September 30, 2026, were $74 million, compared to $11 million in the prior year period.
• Restructuring and impairment costs for the twelve months ended September 30, 2026, were $108 million, compared to $392 million in the prior year period.

Business Segments and Product Lines:

• Americas: Net sales were $1,915 million for the three months ended September 30, 2026, compared to $1,786 million in the prior year period. Adjusted EBITDA was $85 million for the three months ended September 30, 2026, compared to $111 million in the prior year period. Adjusted EBITDA margin was 4.4% for the three months ended September 30, 2026, compared to 6.2% in the prior year period.
• EMEA: Net sales were $1,054 million for the three months ended September 30, 2026, compared to $1,145 million in the prior year period. Adjusted EBITDA was $32 million for the three months ended September 30, 2026, compared to $31 million in the prior year period. Adjusted EBITDA margin was 3.0% for the three months ended September 30, 2026, compared to 2.7% in the prior year period.
• Asia: Net sales were $785 million for the three months ended September 30, 2026, compared to $783 million in the prior year period. Adjusted EBITDA was $136 million for the three months ended September 30, 2026, compared to $106 million in the prior year period. Adjusted EBITDA margin was 17.3% for the three months ended September 30, 2026, compared to 13.5% in the prior year period.

Other Key Points:

• The company recorded a $333 million goodwill impairment and an $8 million impairment of the Adient Aerospace joint venture during the twelve months ended September 30, 2025.
• Share repurchases totaled $45 million for the three months ended September 30, 2026, and $100 million for the twelve months ended September 30, 2026.
• Issuance of long-term debt was $500 million for the three months ended September 30, 2026, and $500 million for the twelve months ended September 30, 2026.
• Repayment of long-term debt, including premium paid, was $549 million for the three months ended September 30, 2026, and $556 million for the twelve months ended September 30, 2026.
• Capital expenditures were $106 million for the three months ended September 30, 2026, and $311 million for the twelve months ended September 30, 2026.
• Dividends paid to noncontrolling interests were $5 million for the three months ended September 30, 2026, and $92 million for the twelve months ended September 30, 2026.
• Adjusted diluted earnings per share for the three months ended September 30, 2026, was $0.52, compared to $0.52 in the prior year period.
• Adjusted diluted earnings per share for the twelve months ended September 30, 2026, was $1.87, compared to $1.93 in the prior year period.
• Adjusted net income attributable to Adient for the three months ended September 30, 2026, was $40 million, compared to $42 million in the prior year period.
• Adjusted net income attributable to Adient for the twelve months ended September 30, 2026, was $147 million, compared to $161 million in the prior year period.